Proteon Therapeutics Garners $15,183,371 New Financing Round

  • Feed Type
  • Date
  • Company Name
    Proteon Therapeutics
  • Mailing Address
    200 West Street Waltham, MA 02451
  • Company Description
    Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy